PUBLICATION
Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis
- Authors
- Patten, S.A., Aggad, D., Martinez, J., Tremblay, E., Petrillo, J., Armstrong, G.A., La Fontaine, A., Maios, C., Liao, M., Ciura, S., Wen, X.Y., Rafuse, V., Ichida, J., Zinman, L., Julien, J.P., Kabashi, E., Robitaille, R., Korngut, L., Parker, J.A., Drapeau, P.
- ID
- ZDB-PUB-171205-12
- Date
- 2017
- Source
- JCI insight 2(22): (Journal)
- Registered Authors
- Armstrong, Gary A.B., Drapeau, Pierre, Patten, Shumoogum, Wen, Xiao-Yan
- Keywords
- ALS, Calcium channels, Clinical Trials, Neurodegeneration, Neuroscience
- MeSH Terms
-
- Neuromuscular Junction Diseases/drug therapy*
- Antipsychotic Agents/pharmacokinetics*
- Antipsychotic Agents/therapeutic use*
- Calcium Channels/drug effects
- Caenorhabditis elegans
- Zebrafish Proteins/metabolism
- Drug Tolerance
- Amyotrophic Lateral Sclerosis/drug therapy*
- DNA-Binding Proteins/metabolism
- Female
- Mice
- Disease Models, Animal
- Calcium Channels, T-Type/drug effects
- Neuromuscular Junction/drug effects
- Zebrafish
- Pimozide/pharmacology
- Animals
- Drug Evaluation, Preclinical
- PubMed
- 29202456 Full text @ JCI Insight
Citation
Patten, S.A., Aggad, D., Martinez, J., Tremblay, E., Petrillo, J., Armstrong, G.A., La Fontaine, A., Maios, C., Liao, M., Ciura, S., Wen, X.Y., Rafuse, V., Ichida, J., Zinman, L., Julien, J.P., Kabashi, E., Robitaille, R., Korngut, L., Parker, J.A., Drapeau, P. (2017) Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI insight. 2(22).
Abstract
Amyotrophic lateral sclerosis (ALS) is a rapidly progressing, fatal disorder with no effective treatment. We used simple genetic models of ALS to screen phenotypically for potential therapeutic compounds. We screened libraries of compounds in C. elegans, validated hits in zebrafish, and tested the most potent molecule in mice and in a small clinical trial. We identified a class of neuroleptics that restored motility in C. elegans and in zebrafish, and the most potent was pimozide, which blocked T-type Ca2+ channels in these simple models and stabilized neuromuscular transmission in zebrafish and enhanced it in mice. Finally, a short randomized controlled trial of sporadic ALS subjects demonstrated stabilization of motility and evidence of target engagement at the neuromuscular junction. Simple genetic models are, thus, useful in identifying promising compounds for the treatment of ALS, such as neuroleptics, which may stabilize neuromuscular transmission and prolong survival in this disease.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping